Molecular Imaging Technologies, LLC (“MIT”) is an outsourced provider of positron emission tomography-computed tomography (“PET/CT”) equipment and services to healthcare facilities throughout the U.S. The Company’s value proposition is to assuage the lofty capital investment that healthcare providers face while also providing turn-key operational and marketing program that integrates into a provider’s workflow. On September 15, 2020, MIT was sold to Alliance Healthcare Services.
Investment Profile:
Status: Realized
Investment Date: September 15, 2011
Transaction Type: Recapitalization (Chapter 11 Plan Purchase)
Strategy: Transformation
Station Lead(s): Rooke
Investment Highlights:
Successful Acquisitions: Metro Region PET Center (Chevy Chase, MD), Oncology Molecular Imaging (5 Locations), Affiliated PET Systems (Silver Spring, MD).
Sale of Core Businesses: Sold core business to strategic buyer in September 2020.
Conversion & Sale of Gadsden PET: Sold last remaining location to a physician group.